Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaginal virucides against HIV].

A B Stone1

  • 1International Family Health, Cityside House, 40, Adler Street, London E1 1EE, Royaume-Uni. alan.stonex@virgin.net

Gynecologie, Obstetrique & Fertilite
|September 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meeting report: panel on the potential utility and strategies for design and implementation of a national companion animal infectious disease surveillance system.

Zoonoses and public health·2008
Same author

Human reproductive cloning.

Journal of the Royal Society of Medicine·1999
Same author

Premenstrual syndrome.

The Psychiatric clinics of North America·1998
Same author

Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.

Journal of clinical psychopharmacology·1997
Same author

Mood disorders and menopause.

Endocrinology and metabolism clinics of North America·1997
Same author

Differentiating bony lesions of the external auditory canal.

Ear, nose, & throat journal·1995

New virucides offer women a self-controlled method to prevent HIV and other sexually transmitted infections. These vaginal applications provide broad-spectrum protection, complementing existing prevention strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Women's Health

Context:

  • Despite ongoing efforts, HIV/AIDS remains a significant global health challenge, necessitating diverse prevention strategies.
  • Existing methods like condoms, while effective, are not always consistently used or preferred by all individuals.
  • There is a critical need for additional, woman-controlled prevention technologies to empower individuals in managing their sexual health.

Purpose:

  • To introduce and discuss the development of virucides as a novel approach to HIV prevention.
  • To highlight the potential of virucides as a woman-controlled, self-administered method for protection against HIV and other STIs.
  • To outline the characteristics and advantages of virucides compared to existing prevention methods.

Summary:

Related Experiment Videos

  • Virucides are anti-infective agents formulated for vaginal application, offering protection against HIV and other sexually transmitted pathogens.
  • These agents are designed for self-administration by women, providing a discreet and controllable option for sexual health.
  • Approximately 60 candidate virucides are in development, with several nearing large-scale clinical trials, indicating promising advancements.

    • Impact:

    • Virucides offer a low-cost, woman-controlled option for self-administered, broad-spectrum protection.
    • They provide a choice of contraceptive and non-contraceptive formulations, catering to diverse user needs.
    • Successful development and implementation of virucides could significantly enhance global HIV/STI prevention efforts and reduce unintended pregnancies.